These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Botulinum A toxin therapy in ophthalmology: a report of patients with facial dystonias. Vissenberg I, Dieleman-Smet H, Tassignon MJ. Bull Soc Belge Ophtalmol; 1993; 248():77-82. PubMed ID: 8044337 [Abstract] [Full Text] [Related]
31. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes. Cillino S, Raimondi G, Guépratte N, Damiani S, Cillino M, Di Pace F, Casuccio A. Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904 [Abstract] [Full Text] [Related]
33. The use of botulinum toxin type A for the treatment of facial spasm. Serrano LA. Bol Asoc Med P R; 1993 Apr; 85(1-3):7-11. PubMed ID: 8060446 [Abstract] [Full Text] [Related]
34. Botulinum toxin for the treatment of essential blepharospasm. Shore JW, Leone CR, O'Connor PS, Neuhaus RW, Arnold AC. Ophthalmic Surg; 1986 Nov; 17(11):747-53. PubMed ID: 3808585 [Abstract] [Full Text] [Related]
35. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. Kenney C, Jankovic J. J Neural Transm (Vienna); 2008 Nov; 115(4):585-91. PubMed ID: 17558461 [Abstract] [Full Text] [Related]